Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.53% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.89% |
| 4 | Industrials | 3.6% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
Blackstone
BX
$112B
| $37.4M | 0.02% |
1,068,800
-189,300
| -15% | -$6.32M |
|
|
CBAY
827
DELISTED
Cymabay Therapeutics
CBAY
| $37.3M | 0.02% |
2,805,472
+1,379,650
| +97% | +$14.7M |
|
828
PUT
Prudential Financial
PRU
$43B
| $37.1M | 0.02% |
404,100
+189,800
| +89% | +$17.5M |
|
|
829
CALL
Honeywell
HON
$74.2B
| $37M | 0.02% |
246,895
+86,260
| +54% | +$12.1M |
|
830
Ovintiv
OVV
$17.2B
| $36.9M | 0.02% |
1,019,771
-3,101,428
| -75% | -$106M |
|
|
DLPH
831
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $36.8M | 0.02% |
1,913,183
-1,263,162
| -40% | -$23.4M |
|
832
Amgen
AMGN
$226B
| $36.8M | 0.02% |
193,620
-118,102
| -38% | -$22.6M |
|
833
PUT
Elevance Health
ELV
$86.4B
| $36.8M | 0.02% |
128,100
+65,300
| +104% | +$18.9M |
|
834
LyondellBasell Industries
LYB
$20.2B
| $36.7M | 0.02% |
436,025
+339,077
| +350% | +$29.3M |
|
835
CALL
Marathon Petroleum
MPC
$100B
| $36.7M | 0.02% |
612,500
+7,000
| +1% | +$440K |
|
836
PUT
US Bancorp
USB
$102B
| $36.5M | 0.02% |
757,600
-38,700
| -5% | -$1.94M |
|
837
AnaptysBio
ANAB
$1.66B
| $36.2M | 0.02% |
496,067
+23,502
| +5% | +$1.62M |
|
838
CALL
Best Buy
BBY
$18B
| $36.2M | 0.02% |
508,800
-109,100
| -18% | -$6.8M |
|
839
CALL
Intuit
INTU
$98B
| $36M | 0.02% |
137,900
-22,400
| -14% | -$5.18M |
|
840
Coca-Cola Europacific Partners
CCEP
$47.5B
| $36M | 0.02% |
695,862
+215,805
| +45% | +$10.2M |
|
841
Ascendis Pharma A/S
ASND
$16.2B
| $36M | 0.02% |
305,876
+209,267
| +217% | +$18.3M |
|
842
CALL
Zimmer Biomet
ZBH
$19B
| $36M | 0.02% |
290,254
+237,415
| +449% | +$27M |
|
|
BHVN
843
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $36M | 0.02% |
698,775
-239,464
| -26% | -$10.3M |
|
844
PUT
RH
RH
$3.4B
| $36M | 0.02% |
349,300
+66,100
| +23% | +$9M |
|
845
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
| $35.9M | 0.02% |
19,150
+14,517
| +313% | +$32M |
|
846
CALL
NXP Semiconductors
NXPI
$58.5B
| $35.8M | 0.02% |
405,200
-352,500
| -47% | -$31M |
|
847
PUT
Kinder Morgan
KMI
$71.4B
| $35.7M | 0.02% |
1,784,100
-714,000
| -29% | -$13.3M |
|
848
CALL
Southwest Airlines
LUV
$22B
| $35.7M | 0.02% |
687,600
+61,200
| +10% | +$3.23M |
|
849
CALL
MongoDB
MDB
$38B
| $35.7M | 0.02% |
242,700
+133,100
| +121% | +$13.7M |
|
850
CALL
Illumina
ILMN
$29.1B
| $35.7M | 0.02% |
118,014
-29,915
| -20% | -$8.72M |
|
Similar funds
Ken Griffin's Q1 2019 Portfolio in Review
As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $13B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.
- Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Ken Griffin opened 1,429 new positions and closed 1,252 in Q1 2019.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.